Financial News
All News about Clovis Oncology Inc
![](https://cdn.benzinga.com/files/images/story/2022/11/09/image-crude-oil.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/09/clvs_logo_light__5d4bac8d84be85d8823f68e5b2264d1d.png?width=1200&height=800&fit=crop)
Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies
November 07, 2022
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2022/10/03/aapharma_9.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/07/clvs1600.png)
![](https://investorplace.com/wp-content/uploads/2022/07/clvs1600.png)
![](https://mms.businesswire.com/media/20221027005119/en/305545/5/Clovis_Logo_Process_Color.jpg)
![](https://mms.businesswire.com/media/20221017005267/en/305545/5/Clovis_Logo_Process_Color.jpg)
![](https://investorplace.com/wp-content/uploads/2021/05/spinoff.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/clvs1600.png)
![](https://investorplace.com/wp-content/uploads/2020/05/pbr-stock-1.jpg)
![](https://mms.businesswire.com/media/20221003005303/en/305545/5/Clovis_Logo_Process_Color.jpg)
![](https://cdn.benzinga.com/files/short_image_331.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/xpev-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/07/clvs1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/aapharma_12.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220921005038/en/305545/5/Clovis_Logo_Process_Color.jpg)
Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
September 21, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image39_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/21/image_4.jpg?width=1200&height=800&fit=crop)
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/20/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image41.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16770.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/image_7.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/adbe-1600-1-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/laboratory-g3987a8c76_1920.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/image17.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.